Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-044546

CEO sold 3,020 shares at $2.25 ($6,795)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Sale : show line 1 in the form −3,020 $2.25 $6,795 1,053,574 D
Open-market sales · 3,020 sh · avg $2.25 · $6,795
Loading xslF345X06/form4.xml…